NDC 0093-5907 – Mesalamine
Mesalamine 400 mg/1 · Capsule, Delayed Release · Oral
Product NDC0093-5907
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Capsule, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA207873
- Marketed since
- May 9, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 400 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0093-5907-86 | 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-5907-86) | May 9, 2019 |
Other Mesalamine products
- 60687-556 Mesalamine 400 mg/1 · Capsule, Delayed Release · American Health Packaging
- 0472-1915 Mesalamine 1000 mg/1 · Suppository · Actavis Pharma, Inc.
- 0591-2245 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Actavis Pharma, Inc.
- 62332-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Limited
- 60687-408 Mesalamine 800 mg/1 · Tablet, Delayed Release · American Health Packaging
- 60687-397 Mesalamine 1.2 g/1 · Tablet, Delayed Release · American Health Packaging
- 60687-650 Mesalamine .375 g/1 · Capsule, Extended Release · American Health Packaging
- 65162-360 Mesalamine 800 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals LLC
- 70954-301 Mesalamine 4 g/60mL · Suspension · ANI Pharmaceuticals, Inc.
- 62559-420 Mesalamine 4 g/60mL · Enema · ANI Pharmaceuticals, Inc.
- 67877-717 Mesalamine .375 g/1 · Capsule, Extended Release · Ascend Laboratories, LLC